Pharmacytimes offers continuing education (CE) courses, career guidance for pharmacy students, online-only articles, digital versions of the print issue, and more, that are essential to pharmacists en-us Fri, 18 Aug 17 14:23:51 +0000 Fri, 18 Aug 17 14:23:51 +0000 Government Scrutiny and Qui Tams The US Department of Justice (&ldquo;DOJ&rdquo;) and the Office of Inspector General (&ldquo;OIG&rdquo;) have become much more aggressive in bringing civil and criminal investigations against pharmacies and their owners. Fri, 18 Aug 17 12:30:00 +0000 Using the Patient Care Process in the Community: Patient-Oriented Care Community pharmacists are valuable health care providers given their accessibility and distribution throughout the community, extended hours of operation, and clinical knowledge. Thu, 17 Aug 17 12:30:00 +0000 Cannabis for Patients with Chronic Pain, PTSD: More Evidence Needed Researchers continue to search for evidence regarding the use of cannabis for medicinal purposes. Thu, 17 Aug 17 12:00:00 +0000 2015-2016 Influenza Season: Live Attenuated Vaccine Ineffective During the 2015-2016 season, influenza vaccines overall reduced the risk of influenza illness, but the live attenuated influenza vaccine (LAIV) was ineffective in children, according to a recently-published study. Wed, 16 Aug 17 13:41:00 +0000 Anxiety Medication Recalled Due to Dosing Dropper Defect Amneal Pharmaceuticals has issued a voluntary nationwide recall of its Lorazepam Oral Concentrate, USP 2mg/mL, due to a defect in the dropper markings that are supplied with the product, according to a company press release. Wed, 16 Aug 17 13:37:00 +0000 NASP Launches Website to Educate About DIR Fees features materials and resources to educate patients, providers, legislators, government administrators, industry analysts, media, and taxpayers about DIR fees, according to the release. Wed, 16 Aug 17 05:30:00 +0000 Case Study: A Pharmacist-Parent Eyes the Zebra Side Effect in a Field Full of Horses How a mother&#39;s intutition, and a pharmacy background, proved important in identifying a medication-related side effect.&nbsp; Mon, 14 Aug 17 05:15:00 +0000 4 New FDA Approvals to Know from July 2017 Learn about the new products and expanded indications approved by the FDA in July 2017. Fri, 11 Aug 17 13:00:00 +0000 Study: Closthioamide for Gonorrhea? Researchers have found a new antibiotic that may have the potential to treat gonorrhea, according to a study published recently in <em>Antimicrobial Agents and Chemotherapy</em>. Thu, 10 Aug 17 12:00:00 +0000 FDA Alert: Liquid Drug Products Contaminated with Burkholderia Cepacia Officials with the FDA are warning health care professionals and patients not to use any liquid product manufactured by PharmaTech LLC, Davie, Florida, due to possible<em> Burkholderia cepacia</em> contamination, according to a safety alert issued by the FDA. Wed, 09 Aug 17 14:39:00 +0000 Lead Poisoning Risk Linked with Balguti Kesaria Officials with the FDA have issued a safety alert warning against the use of &ldquo;Balguti Kesaria (or Kesaria Balguti) Ayurvedic Medicine,&rdquo; due to high levels of lead. Tue, 08 Aug 17 17:41:00 +0000 Risks When Marketing The anti-kickback statute makes it a felony to knowingly and willfully offer, pay, solicit, or receive any remuneration to induce a person (including a legal entity) to refer an individual for the furnishing or arranging for the furnishing of any Medicare-covered item or service. Tue, 08 Aug 17 15:31:00 +0000 Fungal Disease Awareness Week: CDC Wants You to 'Think Fungus' Video series encourages patients to &quot;think fungus&quot; if symptoms don&#39;t improve.&nbsp; Mon, 07 Aug 17 18:39:00 +0000 Judge Issues Injunction Against Pharmacy Company Isomeric allegedly manufactured and distributed purportedly sterile drug products, including injectable and ophthalmic drugs that were adulterated because the drugs were made under insanitary conditions. Fri, 04 Aug 17 19:12:00 +0000 DEA Proposes Reducing Opioid Manufacturing for 2018 Officials with the US Drug Enforcement Administration (DEA) have proposed to cut the amount of controlled substances to be manufactured in 2018 by 20%, compared to 2017,&nbsp;according to a press release. Fri, 04 Aug 17 18:14:00 +0000 Program Targets Opioid Fraud and Abuse To combat the abuse and diversion of opioid medications, Attorney General Jeff Sessions has announced the formation of a new Department of Justice (DOJ) pilot program to crack down on opioid-related health care fraud. Fri, 04 Aug 17 13:16:00 +0000 FDA Advisory Committee Does Not Recommend Sirukumab Although the FDA is not bound by the recommendation of the committee, their advice is taken into consideration.<br /> &nbsp; Fri, 04 Aug 17 01:23:00 +0000 FDA Approves Hepatitis C Drug Officials with the FDA have announced the approval of glecaprevir and pibrentasvir (Mavyret, AbbVie Inc) for hepatitis C.&nbsp; Thu, 03 Aug 17 20:40:00 +0000 FDA Approves Treatment for Acute Myeloid Leukemia The safety and efficacy of Vyxeos were studied in 309 patients with newly diagnosed t-AML or AML-MRC who were randomly assigned to receive Vyxeos or separately administered treatments of daunorubicin and cytarabine. Thu, 03 Aug 17 14:50:00 +0000 FDA Approves Chronic Graft Versus Host Disease Treatment The efficacy and safety of ibrutinib for the treatment of cGVHD were studied in a single-arm trial of 42 patients with cGVHD whose symptoms persisted despite standard treatment with corticosteroids. Wed, 02 Aug 17 19:43:00 +0000 First Oral Treatment for Relapsed, Refractory Acute Myeloid Leukemia Wins FDA Approval Officials with the FDA have approved enasidenib (Idhifa, Celgene Corporation) to treat adult patients with relapsed or refractory acute myeloid leukemia (AML) who have a specific genetic mutation, isocitrate dehydrogenase-2 (IDH2), according to a FDA press release. Tue, 01 Aug 17 17:56:00 +0000 FDA Issues Safety Alert for Compounded Triamcinolone and Moxifloxacin Drug The FDA has issued a safety alert after receiving serious adverse events reports regarding intravitreal (eye) injections of a medication containing triamcinolone and moxifloxacin. Mon, 31 Jul 17 14:16:00 +0000 Dermatology Drug Manufacturer to Cease Distribution of Unapproved Products Tennessee drug company Crown Laboratories Inc. has agreed to cease the manufacturing and distribution of unapproved and misbranded dermatologic creams and lotions. Thu, 27 Jul 17 19:18:00 +0000 Pharmacist, Pharmacy Marketer Plead Guilty in Compound Medication Schemes A Mississippi pharmacist in charge of a compounding pharmacy pleaded guilty to his role in a $192 million compounded medication scheme, according to the Department of Justice (DOJ). Thu, 27 Jul 17 19:16:00 +0000 Pharmacists Rank on Glassdoor's Most Competitive In-Demand Jobs List Pharmacists continue to rank among best-paying professions, but competition in the job market is high. &nbsp; Thu, 27 Jul 17 16:11:00 +0000